- Home
- PLBY vs RLYB Comparison
PLBY vs RLYB Comparison
Compare PLBY & RLYB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLBY
- RLYB
- Stock Information
- Founded
- PLBY 1953
- RLYB 2018
- Country
- PLBY United States
- RLYB United States
- Employees
- PLBY N/A
- RLYB N/A
- Industry
- PLBY Recreational Games/Products/Toys
- RLYB Biotechnology: Pharmaceutical Preparations
- Sector
- PLBY Consumer Discretionary
- RLYB Health Care
- Exchange
- PLBY Nasdaq
- RLYB Nasdaq
- Market Cap
- PLBY 138.1M
- RLYB 14.4M
- IPO Year
- PLBY N/A
- RLYB 2021
- Fundamental
- Price
- PLBY $1.79
- RLYB $0.42
- Analyst Decision
- PLBY Buy
- RLYB Hold
- Analyst Count
- PLBY 2
- RLYB 3
- Target Price
- PLBY $1.85
- RLYB $15.00
- AVG Volume (30 Days)
- PLBY 327.4K
- RLYB 8.2M
- Earning Date
- PLBY 08-07-2025
- RLYB 08-07-2025
- Dividend Yield
- PLBY N/A
- RLYB N/A
- EPS Growth
- PLBY N/A
- RLYB N/A
- EPS
- PLBY N/A
- RLYB N/A
- Revenue
- PLBY $116,691,000.00
- RLYB $848,000.00
- Revenue This Year
- PLBY $3.96
- RLYB N/A
- Revenue Next Year
- PLBY $1.75
- RLYB N/A
- P/E Ratio
- PLBY N/A
- RLYB N/A
- Revenue Growth
- PLBY N/A
- RLYB N/A
- 52 Week Low
- PLBY $0.52
- RLYB $0.22
- 52 Week High
- PLBY $2.44
- RLYB $1.54
- Technical
- Relative Strength Index (RSI)
- PLBY 70.68
- RLYB 56.74
- Support Level
- PLBY $1.81
- RLYB $0.36
- Resistance Level
- PLBY $1.95
- RLYB $0.45
- Average True Range (ATR)
- PLBY 0.12
- RLYB 0.05
- MACD
- PLBY 0.02
- RLYB 0.01
- Stochastic Oscillator
- PLBY 83.53
- RLYB 35.31
About PLBY PLBY Group Inc.
PLBY Group Inc connects consumers around the world with products, services, and experiences to help them look good, feel good, and have fun. PLBY Group serves consumers in four categories: Style and Apparel, Digital Entertainment and Lifestyle, Sexual Wellness, and Beauty and Grooming. It operates through three segments Direct-to-Consumer, Licensing, and Digital Subscriptions and Content. It generates revenue through the sales of products and content services to consumers.
About RLYB Rallybio Corporation
Rallybio Corp is a clinical stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare disorders. The programs of the company are for the prevention of fetal and neonatal alloimmune thrombocytopenia, a potentially life-threatening rare disease that can cause uncontrolled bleeding in fetuses and newborns.